Zonagen (zona) - good buy? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bruce Rosen who wrote (6209)	2/18/1999 12:01:00 PM
From: Hank	Read Replies (1) of 7041

Yes, but the "experts" on this thread claimed that Vasoscam was selling well in Mexico and that the 4Q numbers would prove so. Just go back and read their comments following the 3Q report. Schering has to proceed as though Vasoscam will get approved. It wouldn't be good business to not be ready for a full scale marketing attack in the event that approval does happen. As for the theory that Schering is gathering additional data in Mexico, so what if they are? It would have no relevance to getting approval in this country because the application has already been filed. Also, it is not standard practice for a drug company to submit data from studies in a third world company when seeking approval from the FDA. It doesn't make any sense. If they wanted additional clinical data, then why not conduct the studies here where the experimental conditions can be better controlled? I doubt that there's an advantage to conducting these types of studies in a country where the medical facilities are significantly inferior to our own (unless you're looking to do it in such a way as to skew the results in your favor).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next